Archives
-
Targeted EPO mRNA Nanoparticles for Spinal Cord Repair
2026-09-22
This study developed mannose-modified lipid nanoparticles that deliver human erythropoietin mRNA to CD206-enriched inflammatory macrophages and microglia after spinal cord injury. In mice, localized EPO production was associated with reduced neuroinflammation, suppression of ferroptosis-related damage, preservation of serotonergic axons, and improved motor recovery.
-
In Vitro Drug Responses: Viability and Cell Death
2026-09-22
Hannah R. Schwartz’s dissertation separates drug-induced growth inhibition from cell killing, showing that conventional viability measurements can combine biologically distinct outcomes. Its framework helps researchers design cancer drug experiments that distinguish proliferative arrest, death magnitude, and response timing rather than treating a single viability value as a complete phenotype.
-
Erlotinib (NSC 718781) in EGFR Assays
2026-09-21
Erlotinib (NSC 718781) provides a practical way to connect ATP-competitive EGFR inhibition with phosphorylation, proliferation, apoptosis, and receptor-complex biology. This workflow shows how to pair short-term pathway assays with longer phenotypic studies and CXCR4–EGFR heteromer measurements.
-
CD28–ARS2 Control of PKM Splicing in CD8+ T Cells
2026-09-21
The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in mature CD8+ T cells, favoring PKM2 and enabling flexible glucose use, interferon-γ production, and antitumor activity. Its main contribution is to separate this splicing-dependent metabolic program from canonical CD28–PI3K signaling, providing a mechanistic framework for studying T-cell immunometabolism.
-
Entecavir in HBV Cell-Assay Workflows
2026-09-20
A practical, evidence-based guide to using Entecavir (SKU BA1816) in HBV replication, viability, proliferation, and cytotoxicity workflows. It explains assay interpretation, DMSO formulation, controls, resistance modeling, and criteria for selecting a reliable research-grade supplier.
-
PTPN2 Targets STING–STAT3 in Psoriasis
2026-09-19
A 2026 Immunobiology study identifies PTPN2 as a negative regulator of the STING–STAT3 axis in psoriasis-like inflammation. Using keratinocyte experiments and imiquimod-induced mice, the authors link PTPN2-dependent STING dephosphorylation to reduced inflammation, enhanced autophagy and apoptosis, and improved tissue pathology.
-
MAPK10–KRT16 Axis in NSCLC Metastasis
2026-09-18
The reference study identifies a phosphorylation-dependent MAPK10–KRT16–RNF213 pathway that limits non-small cell lung cancer metastasis by directing KRT16 toward ubiquitination and proteasomal degradation. Its combination of mechanistic, cellular, animal, and clinical evidence positions this axis as a useful framework for studying metastatic regulation, while also highlighting the need for pathway-specific validation before therapeutic translation.
-
MLKL Polymerization and Lysosomal Permeabilization
2026-09-18
The reference study identifies lysosomal membrane permeabilization as a major execution step in necroptosis caused by polymerized MLKL. Its imaging, perturbation, and mechanistic experiments connect MLKL recruitment to lysosomes with cathepsin B release and cell death, refining how the necrosome damages cells.
-
L-Glutathione Reduced in GOT1 Redox Assays
2026-09-17
Use L-Glutathione Reduced as a controlled thiol reagent to separate redox rescue from GOT1-driven metabolic effects in pancreatic cancer models. Its aqueous solubility, fresh-solution workflow, and GST compatibility also support reproducible enzyme, affinity, and oxidative-stress experiments.
-
EdU Flow Cytometry Assay Kits (Cy3): S-Phase Workflows
2026-09-17
EdU Flow Cytometry Assay Kits (Cy3) provide a direct S-phase readout for cancer biology, pharmacodynamic studies, and genotoxicity testing without DNA denaturation. This guide translates TK1-focused endometrial cancer findings into practical assay design, controls, optimization steps, and troubleshooting strategies.
-
WDR36, Glycolysis, and Human Trophectoderm Fate
2026-09-16
The reference study identifies WDR36 as a regulator of trophectoderm differentiation in human blastoid models and connects its activity to glycolytic metabolism through LDHA. By combining mouse embryo experiments with human stem cell-derived blastoids, transcriptomics, targeted metabolomics, and protein-interaction analysis, the work provides a mechanistic framework for understanding early developmental arrest.
-
Tobramycin: Mechanism, Evidence, and Lab Use
2026-09-16
Tobramycin is an aminoglycoside antibiotic and bacterial protein synthesis inhibitor used in microbiology research. Its 30S-ribosome activity, defined product specifications, and comparative susceptibility evidence support controlled studies of antibacterial mechanisms and antibiotic resistance.
-
Penicillin G Sodium: Research Workflows
2026-09-15
Build reproducible Gram-positive challenge assays with Penicillin G Sodium, from aqueous stock preparation through MIC, time-kill, and barrier-model validation. The workflow separates true cell-wall-targeted activity from strain-specific resistance, compound instability, and experimental contamination.
-
Kanamycin Sulfate in circRNA Workflows
2026-09-15
Kanamycin Sulfate provides dependable bacterial selection upstream of plasmid preparation, while ultrafiltration addresses the separate challenge of enriching circular RNA. This workflow guide connects antibiotic selection, circRNA production, membrane choice, and troubleshooting without treating kanamycin as a direct RNA purification reagent.
-
L-Alanyl-L-Glutamine: Protocol and QC Guide
2026-09-14
L-Alanyl-L-Glutamine (SKU B8228) provides a defined, water-soluble L-Ala-L-Gln dipeptide for aqueous gastrointestinal, epithelial-barrier, and nutritional workflow development. This guide covers dissolution, handling, QC, and study controls; it should not be treated as evidence of a validated dose, clinical benefit, or compatibility with DMSO or ethanol systems.